Results 141 to 150 of about 15,755 (201)

Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapies. [PDF]

Front Oncol
Cavo M, Bringhen S, Buda G, Di Raimondo F, Musto P, Offidani M, Petrucci MT, Zamagni E, Zambello R, Berruto F, Freddi R, La Malfa P.   +11 more
europepmc   +1 more source

Daratumumab-based salvage therapy enables umbilical cord blood transplantation in multiline refractory, elderly T-lymphoblastic lymphoma: a case report. [PDF]

Front Immunol
Yang Q, Yang L, Cai P, Ji YH, Zhou JD, Qian J.   +5 more
europepmc   +1 more source

Infection risks associated with daratumumab-containing regimens in multiple myeloma: a systematic review and meta-analysis. [PDF]

Front Oncol
Huang ZY, Liu XL, Li T, Luo CH.
europepmc   +1 more source

Efficacy and Safety of Anti-CD38 Antibody-Containing Triplet Regimens in Frail Patients with Multiple Myeloma. [PDF]

Cancers (Basel)
Iriuchishima H, Saito A, Mihara M, Kanaya S, Yoshizawa R, Isoda A, Matsumoto M.   +6 more
europepmc   +1 more source

Treatment with Daratumumab in Combination with Glucocorticosteroids as First-Line Treatment Achieves a Complete Remission for a Patient with Multiple Myeloma and Resolves Neutropenia: A Case Report. [PDF]

Case Rep Oncol
Mettias S, Cheung J, Moore J, Berenson JR.   +3 more
europepmc   +1 more source

Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial. [PDF]

Nat Commun
Ostendorf L, Zernicke J, Klotsche J, Kempkens R, Beenken AE, Biesen R, Cheng Q, Khodadadi L, Guerra GM, Heinrich F, Durek P, Burmester GR, Krönke G, Hiepe F, Mashreghi MF, Alexander T.   +15 more
europepmc   +1 more source

Resolving the Interference of Anti-CD38 Antibodies on Blood Compatibility Assays Using CD38 "Baitbodies" Approach. [PDF]

J Immunol Res
Gnann DC, Steinke S, Garritsen HSP, Hust M.   +3 more
europepmc   +1 more source

Patient with AL amyloidosis with recurrent syncope as the first symptom: case report and literature review. [PDF]

Front Oncol
Hu L, Luo L, Yao N, Mi J, Zhang Y, Sun M, Wang H, Xu Y, Wang W, Hu J, Lu H.   +10 more
europepmc   +1 more source

Safety and efficacy of daratumumab in immune thrombocytopenia. [PDF]

Blood Adv
Tsykunova G, Holme PA, Tran HTT, Frederiksen H, Tjønnfjord E, Munthe LA, Drivet E, Kared H, Sørvoll IH, Ahlen MT, Mahévas M, Michel M, Bussel J, Kuter DJ, Anderson Tvedt TH, Ghanima W.   +15 more
europepmc   +1 more source